For the latest news and information about the coronavirus pandemic, visit the WHO website.
The U.S. Department of Health (HHS) has agreed to buy 500,000 remdesivir treatment courses after clinical studies have shown that the drug can help patients recover from the disease Corona virusmore quickly. A five-day course costs $ 2,340 or $ 3,120 for commercially insured patients, according to the biotech company Gilead Sciences.
Earlier last month, the Food and Drug Administration granted an emergency approval for the use of remdesivir in COVID-19 that “hospitalized” patients with serious illness shortly after the drug had “clearly positive effects” in a US study would have .
“We want to ensure as much as possible that every American patient who needs remdesivir can get it,” said HHS secretary Alex Azar in a press release.
This story will be updated shortly.
The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a doctor or other qualified healthcare provider if you have any questions about an illness or health goals.